Medtronic 2013 Annual Report Download - page 10

Download and view the complete annual report

Please find page 10 of the 2013 Medtronic annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 145

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145

75732me_editorial.indd 6 6/28/13 3:39 PM
Cardiac and Vascular Group
The Cardiac and Vascular Group (CVG) consists CVG FY2013 Revenue:
of four businesses: Cardiac Rhythm Disease
Management (CRDM), Coronary, Structural Heart,
6 | 2013 Medtronic Annual Report
Endurant AAA Stent
Graft System
Eugene Sandvig
Former Olympic speed skater Gene Sandvig stayed in shape
by playing golf and chasing after his grandchildren. He
considered himself healthy, but learned otherwise during
an annual checkup: a screening for an abdominal aortic
aneurysm (AAA) showed a weakness in the wall of Gene’s
aorta, not uncommon in men over 60. A vascular surgeon
repaired Gene’s AAA with the Endurant AAA stent graft
system, creating a new pathway for blood ow through
his main artery. He went home the next day and shortly
thereafter resumed his active life as a golfer and grandfather.
$8.70 Billion
(in millions)
Pacing
Systems $1,906
Atrial Fibrillation
and Other $243
Debrillation
Systems $2,773
Coronary $1,773
Structural Heart $1,133
Endovascular $867
Product Categories
*Not approved for commercial distribution in the United States.
Ablation products
Aortic stent graft systems
Coronary angioplasty technologies
CRDM device information
management systems
Electrophysiology catheters
Implantable debrillators
Leads and delivery systems
Open heart and coronary bypass
grafting surgical products
Pacemakers
Peripheral angioplasty technologies
Renal denervation for uncontrolled
hypertension*
Surgical heart valves
Tissue ablation systems
Transcatheter heart valves
and Endovascular. The primary products sold
include those for cardiac rhythm disorders and
cardiovascular disease.
Highlights:
• CRDMlaunchedJapan’srstMR-conditional
pacing system in October, Advisa MRI, which
resulted in more than 11 points of share gain.
Advisa MRI launched in the U.S. later in the
scal year.
• CoronarylaunchedtheResoluteIntegrity
drug-eluting stent in Japan for the treatment of
coronary artery disease, which followed an earlier
launch in the U.S. that resulted in 20 points of
market share gain.
• Endovascularcompletedenrollmentinthe
IN.PACT Admiral drug-eluting balloon U.S. pivotal
trial to evaluate the use of the product for the
treatment of peripheral artery disease.
• StructuralHeartcompletedenrollmentintheU.S.
pivotal trial for the CoreValve transcatheter aortic
valve system in high-risk patients and began
enrollment in the global SURTAVI trial evaluating
CoreValve in intermediate-risk patients.
Cardiac Rhythm Disease Management